Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 | MicrobiomeTrials← Back to trialsNCT02311621
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2014-11-25Est. Completion: 2023-11
Enrollment target: 65 participants Locations- Seattle Children's Hospital, Seattle, Washington, United States
Other microbiome trials you might be interested in
Ganglioneuroblastoma, NodularNeuroblastoma
This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care su…
Birmingham, United StatesEst. completion Dec 31, 2029
Endocrine TumorsThyroid NeoplasmsParathyroid NeoplasmsAdrenal NeoplasmNeuroblastoma
Background:
* Endocrine neoplasms (tumors) are among the fastest growing tumors in incidence in the United States. Furt…
Bethesda, United States
Solid TumorsBrain TumorsSarcomaPediatric CancersNeuroblastoma
BACKGROUND:
* Despite progress, some children and young adults with solid tumors still experience poor survival.
* Acti…
Bethesda, United StatesCompleted Sep 8, 2015